A detailed history of Bruce G. Allen Investments, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 33 shares of REGN stock, worth $27,207. This represents 0.03% of its overall portfolio holdings.

Number of Shares
33
Previous 42 21.43%
Holding current value
$27,207
Previous $44.1 Million 21.41%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$1024.09 - $1201.76 $9,216 - $10,815
-9 Reduced 21.43%
33 $34.7 Million
Q2 2024

Jul 12, 2024

BUY
$883.2 - $1071.19 $4,416 - $5,355
5 Added 13.51%
42 $44.1 Million
Q1 2024

Apr 10, 2024

SELL
$902.69 - $993.35 $7,221 - $7,946
-8 Reduced 17.78%
37 $35.6 Million
Q4 2023

Jan 10, 2024

BUY
$775.18 - $881.7 $34,883 - $39,676
45 New
45 $39.5 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $88.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.